NCT06274437 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06274437
Title	A Study of BND-35 in Participants With Advanced Solid Tumors
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Biond Biologics
Indications	gastric adenocarcinoma colorectal cancer renal cell carcinoma esophagus squamous cell carcinoma lung non-small cell carcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma pancreatic adenocarcinoma breast cancer melanoma esophagus adenocarcinoma cholangiocarcinoma ovarian cancer sarcoma Advanced Solid Tumor
Therapies	BND-35 + Cetuximab BND-35 + Nivolumab BND-35
Age Groups:	adult \| senior
Covered Countries	ISR

Facility	City	Zip	Country	Details
Rambam Health Care Campus	Haifa	3109601	Israel	Details
Hadassah University Medical Center	Jerusalem	91120	Israel	Details
Rabin Medical Center	Petah Tikva	49100	Israel	Details
Sheba Medical Center	Ramat Gan	52621	Israel	Details
Tel Aviv Sourasky Medical Center	Tel Aviv	6423906	Israel	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06274437Clinical Trial Detail